Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C22H27N5O4.4ClH.H2O |
Molecular Weight | 1014.821 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.Cl.Cl.Cl.OCCNCCNC1=CC=C2N(CCNCCO)N=C3C2=C1C(=O)C4=C3C=CC=C4O.OCCNCCNC5=CC=C6N(CCNCCO)N=C7C6=C5C(=O)C8=C7C=CC=C8O
InChI
InChIKey=CNQCTSLNJJVSAU-UHFFFAOYSA-N
InChI=1S/2C22H27N5O4.4ClH.H2O/c2*28-12-9-23-6-7-25-15-4-5-16-20-19(15)22(31)18-14(2-1-3-17(18)30)21(20)26-27(16)11-8-24-10-13-29;;;;;/h2*1-5,23-25,28-30H,6-13H2;4*1H;1H2
Losoxantrone is an anthrapyrazole that induces both single and double strand breaks in DNA and is a potent inhibitor of DNA synthesis. The drug is in clinical trials for the treatment of breast cancer and of prostate cancer that is refractory to androgen ablation. Acute toxicity is negligible. Losoxantrone may be less cardiotoxic than doxorubicin. Up to 40% of patients encounter alopecia. 3% of patients develop congestive heart failure. Losoxantrone had been in phase II clinical trial for the treatment of breast and prostate cancer. However, this development was discontinued.
Originator
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2107
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DD-76
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
W6E275IURX
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
C72077
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL83520
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
166541
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
DTXSID70157873
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
357885
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
132937-89-4
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
SUB02975MIG
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY | |||
|
100000086173
Created by
admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD